Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Dynamic Light Scattering (DLS)

Dynamic light scattering (DLS) is a Biophysical Technique that enables particles to be distinguished on the basis of their size. Sygnature have experience in the utilisation of this technique; using the Viscotek DLS reader, to interrogate the stoichiometry of protein-protein interactions and to identify aggregating compounds or non-specific inhibitors, adding value to our client’s discovery programs via hit validation, protein characterisation and assay troubleshooting.

DLS enables an assessment of compound, protein or protein-ligand binding complex aggregation behaviour by measuring the correlation between the intensity of scattered light over a time course. The correlation between time points is used to determine the radii of nanometre-scale objects in solution.

Dynamic Light Scattering

Dynamic Light Scattering

Figure A: DLS data for a compound at aggregating and sub-aggregating concentrations, illustrating the raw correlation functions (left) and the corresponding intensity distribution (right).  Aggregation is indicated by peaks to the right of those observed in the buffer blank.

Latest News

View All

Sygnature Discovery and Daewoong Pharma announce research…

New platform set to accelerate early-stage targeted…

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…